# AMBERSTONE BIOSCIENCES, INC. — Form D/A

AMBERSTONE BIOSCIENCES, INC. of LAGUNA HILLS, CA, a company, filed a Form D amendment with the SEC on 2021-12-20. The offering totals $12.0M, of which $6.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-12-20
- Form: D/A
- Accession: 0001896218-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $6.0M
- Remaining: $6.0M
- Investors: 6
- Date of first sale: 2021-11-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-425686

## Issuer

- Name: AMBERSTONE BIOSCIENCES, INC.
- CIK: 0001896218
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 23181 VERDUGO DR, LAGUNA HILLS, CA, 92653
- Phone: 9492697918

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Yonglei Guikai Shang | Director | Laguna Hills, CA |
| George Guikai Wu | Director | Laguna Hills, CA |
| Weian Guikai Zhao | Director | Laguna Hills, CA |
| Yonglei Guikai Shang | Executive Officer | Laguna Hills, CA |
| George Guikai Wu | Executive Officer | Laguna Hills, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-12-17](https://search.stillhousedata.com/formd/0001896218-21-000002) | D | $12.0M | $6.0M |

## More

- [CIK 1896218 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1896218&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001896218-21-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.